Symptomtext
administering an expired product, with no adverse event; Initial information received on 21-Nov-2022 regarding an unsolicited valid non-serious case received from a other health professional. This case involves a female patient of unknown age to whom expired HIB (PRP/T) Vaccine [ACT-HIB] was administered, with no adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 07-Nov-2022, the patient received a dose of expired HIB (PRP/T) Vaccine (expired product administered) (latency: same day) (lot UJ586AAA and expiry date - 16-Oct-2022) (strength, dose, route, formulation unknow) via unknown route in unknown administration site for Immunization. Action taken: not applicable. It was not reported if the patient received a corrective treatment for the event. At time of reporting, the outcome was Unknown for the event. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.